| Ten Years of Experience with the GORE EXCLUDER(®) Stent-Graft for the Treatment of Aortic and Iliac Aneurysms: Outcomes from a Single Center Study. | |
| | |
MedLine Citation:
|
PMID: 21822771 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE: This study was designed to assess the long-term outcome of selected patients with aortic, aortoiliac, and isolated common iliac aneurysms treated with the GORE EXCLUDER(®) stent-graft. METHODS: Between December 1998 and June 2010, 121 nonconsecutive patients underwent insertion of a GORE EXCLUDER(®) stent-graft to treat an aortic (n = 80; 66%), aortoiliac (n = 25; 21%), or isolated common iliac (n = 16; 13%) aneurysm. Procedural and follow-up data were collected prospectively. Primary endpoints are overall survival, intervention-free survival, and freedom from aneurysm rupture. Secondary endpoints are device- and procedure-related complications, including all types of endoleaks or endotension, and reintervention. RESULTS: The mean follow-up is 4.98 years (standard deviation, 3.18; median follow-up, 4.05 years). The estimated percentage overall survival (with 95% confidence interval) after respectively 5 and 10 years of follow-up is 74.5% (65.8; 81.3) and 57.8% (47.7; 66.7). The estimated intervention-free survival after respectively 5 and 10 years is 90% (84.3; 96.1) and 77.7% (67; 88.4). There was no aneurysm rupture during follow-up. Early postoperative complications occurred in 16 patients (13%); none were fatal. Late reinterventions were performed in 18 patients (15%). Finally, throughout the follow-up period, endoleaks were identified: type I (n = 4; 3%); type II (n = 39; 32%); type III (n = 0; 0%); endotension was seen in 11 patients (9%). CONCLUSIONS: Aneurysm exclusion with use of the GORE EXCLUDER(®) stent-graft is durable through a mean follow-up of nearly 5 years. There was no postprocedural aneurysm rupture. Complications occurred throughout the follow-up period, requiring continued clinical and radiological surveillance. |
| | |
Authors:
|
G Maleux; H Claes; A Van Holsbeeck; R Janssen; A Laenen; S Heye; S Houthoofd; I Fourneau |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2011-8-6 |
Journal Detail:
|
Title: Cardiovascular and interventional radiology Volume: - ISSN: 1432-086X ISO Abbreviation: - Publication Date: 2011 Aug |
Date Detail:
|
Created Date: 2011-8-8 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8003538 Medline TA: Cardiovasc Intervent Radiol Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Radiology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium, geert.maleux@uzleuven.be. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chemoembolization for Hepatocellular Carcinoma Supplied Exclusively by the Hepatic Falciform Artery.
Next Document: Carbon monoxide exposure enhances arrhythmia after cardiac stress: involvement of oxidative stress.